4Mongirdiene A,Kursvietiene L,Kasauskas A. The coagulation system changes in patients with chronic heart failure [J]. Medicina ( Kaunas), 2010,46 (9) : 642-647.
5Carpenter CR, Keim SM, Worster A, et al. Brain natriuretic peptide in the evaluation of emergency department dyspnea: is there a role? [J]. J Emerg Meal,2012,42(2) :197-205.
5Strunk A,Bhalla V,Clopton P,et al.Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure:Result form the breathing not properly multinational study[J].The American journal of Medicine,2006,119(69):1-11.
6Lee SC,Stevens TL,Sandberg SM,et al.The potential of brain natriuretic peptide as & biomarker for New York Heart Association class during the outpatient treatment of heart failure[J].J Card Fail,2002,8(3):149-154.
7Law Y, Kell B, Feingold B, et al. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart diease[J]. Am J Cardio, 2005,95: 474-478.
8Doust JA, Pietrzak E, Dobson A, et al. How well does B-type natriuretic peptide predict death and Cardiac events in patients with heart failure: systematic review[J]. Br Med J, 2005, 330: 625-633.
9Alans S, Peter A. Cardiac natriuretic peptides : A proten window to cardiac function and clinical management[J]. J Rev cardio-vasc Med, 2003, 4(suppl4): 3-12.
10Maisel AS,Koon J,Krishnaswamy P,et al. Utility of B-natriuretic peptide as a rapid point-of-care test for screening patients undergoin echo-cardiography to determine left ventricular dysfunction [J]. Am Heart J, 2001,141 (3) : 367-374.
3Tavazzi L, Senni M, Metra M, et al .Multicenter prospective ob- servational study on actue and chronic heart failure: One - year follow - up results of IN-HF (Italian Netwok on Heart Failure) outcome registry[J] .Cir Heart Fail, 2013, 6(3) : 473 - 481.
4Pressler SJ.Comgnitive functioning and chronic heart failure: A review of literature (2002 - July 2007)[J].J Cardiovasc Nurs, 2008,23(3) : 239 - 249.
5Vanderheyden M,Vrints C, Verstreken S, et al .B -type natri- uretic peptide as a marker of heart failure: New Insights from bio chemistry and clincal implications[J].Biomark Med,2010,4(2) :315.
6Silva D, Cortez- Dias N, Jorge C, et al .Cystatin C as prognostic biomarker in ST- segment evevation acute myocardial infarction [J].Am J Cardiol, 2012,109(10) : 1431 - 1438.
7Maisel A, Barnard D,Jaski B, et al .Primary results of the HABIT Trial(heart failure assessment with BNP in the home)[J].J Am Coil Cardiol, 2013,61 (16) : 1726 - 1735.
8Angelidis C, Deftereos S, Giannopoulos G, et al .Cystatin C: An emerging biomarker in cardiovascular disease[J].Curr Top Med Chem,2013,13(2) : 164 - 179.
